Vista Current Coverage

All Topics Articles

Shares of Gene Therapy Firm AveXis Surge on Novartis’ Buyout

Novartis (NVS) has agreed to pay $218/share for gene therapy firm AveXis (AVXS), a 88% premium to April 6th’s closing price. This gives Novartis, a Swiss drug giant, several treatments for rare diseases based on gene therapy. Vas Narasimhan stated on a conference call, “We’re in...

How Would $1 Million Work for You This Year?

Bloomberg reported that a Japanese firm called Today Co., which operates a popular online fashion shopping site Zozotown, posted new job offerings recently seeking up to seven “genius” tech experts. What is amazing is that they are willing to pay nearly $1 million or 100 million...